# Vertex Pharmaceuticals Incorporated - Inspection Records

Source: https://www.keypedia.com/companies/vertex-pharmaceuticals-incorporated/f2bc62b8-1ece-42d2-b058-39466a256c74

> Inspection records and compliance data for Vertex Pharmaceuticals Incorporated in Boston, Massachusetts. Access full analysis and detailed observations.

---

## Details

- Name: Vertex Pharmaceuticals Incorporated
- FEI Number: 1000513211
- City: Boston
- State: Massachusetts
- Country Name: United States
- Address Line 1: 50 Northern Ave
- Zip Code: 02210

## Related Documents

- [FDA Inspection 1306258 - Vertex Pharmaceuticals Incorporated - 2026-03-03](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/39438762-62e2-4992-8b2c-9619e8660021) — source: FDA, date: March 3, 2026
- [FDA Inspection 1306258 - Vertex Pharmaceuticals Incorporated - 2026-03-03](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/bc146f43-1e81-4339-a15b-d826e903c323) — classification: No Action Indicated (NAI), source: FDA, date: March 3, 2026
- [FDA Inspection 1246447 - Vertex Pharmaceuticals Incorporated - 2024-08-01](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/c4ab424b-474e-495d-9305-8ea1aaab2658) — classification: No Action Indicated (NAI), source: FDA, date: August 1, 2024
- [483 - Vertex Pharmaceuticals Incorporated - 2023-05-04](https://www.keypedia.com/records/483/vertex-pharmaceuticals-incorporated/5261a188-7e21-4926-88da-807f338c3960) — source: FDA, date: May 4, 2023
- [FDA Inspection 1205834 - Vertex Pharmaceuticals Incorporated - 2023-05-04](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/4cbf0acd-6531-444b-9f0e-e38d042a7300) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 4, 2023
- [FDA Inspection 1180001 - Vertex Pharmaceuticals Incorporated - 2022-08-19](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/2a08f2c0-64e1-485c-b0c0-b743e6cc1e54) — classification: No Action Indicated (NAI), source: FDA, date: August 19, 2022
- [FDA Inspection 1029564 - Vertex Pharmaceuticals Incorporated - 2017-10-05](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/ef449ae2-6306-4b62-a369-7b0b42a98023) — classification: No Action Indicated (NAI), source: FDA, date: October 5, 2017
- [FDA Inspection 988733 - Vertex Pharmaceuticals Incorporated - 2016-09-21](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/7baeff73-fdc6-4de1-a6ea-022969fc8028) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 21, 2016
- [FDA Inspection 926154 - Vertex Pharmaceuticals Incorporated - 2015-04-29](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/c9d0f7be-c837-48e7-9689-03fbb3fb360d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 29, 2015
- [FDA Inspection 916736 - Vertex Pharmaceuticals Incorporated - 2015-02-17](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/cb597169-8f34-4c11-8171-0a7eac42ae89) — classification: No Action Indicated (NAI), source: FDA, date: February 17, 2015
- [FDA Inspection 902520 - Vertex Pharmaceuticals Incorporated - 2014-10-16](https://www.keypedia.com/records/fda_inspections/vertex-pharmaceuticals-incorporated/3c55544b-fd12-4239-9caa-59a431d5894f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 16, 2014

## Related Companies

- [Alkermes Inc](https://www.keypedia.com/companies/alkermes-inc/c20f3273-400d-4b2e-a485-214b986ed7c2)
- [Seqirus Vaccines Limited](https://www.keypedia.com/companies/seqirus-vaccines-limited/6ad0915f-2ffc-46ca-be22-7620c05657c7)
- [Noven Pharmaceuticals Inc](https://www.keypedia.com/companies/noven-pharmaceuticals-inc/78cbceb0-5494-46a4-be87-8acf4450fa52)
- [Blistex Inc](https://www.keypedia.com/companies/blistex-inc/5268fd01-ac61-4bf8-a1ca-192da45c825a)
- [AustarPharma, LLC](https://www.keypedia.com/companies/austarpharma-llc/05a402ea-dcb1-4900-9553-0a3a1b908183)
- [Catalent Pharma Solutions, LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/311196d9-b80d-4a77-a294-dab360325781)
- [Alexza Pharmaceuticals, Inc.](https://www.keypedia.com/companies/alexza-pharmaceuticals-inc/4b71680e-1a0e-4237-8b2a-2e2c32c5c8fe)
- [Glatt Air Techniques, Inc.](https://www.keypedia.com/companies/glatt-air-techniques-inc/c6956abd-d6ba-4f55-a73a-1aab096eb238)
- [Apotex, Inc.](https://www.keypedia.com/companies/apotex-inc/3fb3d66a-fef9-4c47-82b5-da446ecf3593)
- [Pharmaceutical Manufacturing Research Services, Inc (PMRS)](https://www.keypedia.com/companies/pharmaceutical-manufacturing-research-services-inc-pmrs/46e43916-458b-4d9f-8d90-0106b93f9908)

## Related Officers

- [Robert J. Martin](https://www.keypedia.com/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae)